PS · Pershing Square Inc.
Price & Indicators
The closing range uses available history since Apr 29, 2026; less than a full year is stored.
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| FRE revenue non-GAAP | 25% | the three months ended June 30, 2026 filing | — |
| Total Assets Under Management Ending Balance | $32.49B | the three months ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Asset Management — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PS
this stock
Pershing Square Inc.
|
$16.87B | — | — | — | 0.1% |
|
BLK
BlackRock, Inc.
|
$375.52B | +8.8% | +16.2% | 27.7 | 0.6% |
|
BX
Blackstone Inc.
|
$107.52B | -7.6% | +9.2% | 32.1 | 2.9% |
|
KKR
KKR & Co. Inc.
|
$97.56B | -14.7% | -11.0% | — | 1.4% |
|
BN
BROOKFIELD Corp /ON/
|
$92.02B | -9.9% | — | — | 0.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PS | +5.3% | +26.7% | — | +26.7% | — |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | +4.8% | +23.7% | — | +23.7% | — |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.